Theravance Biopharma (TBPH) EPS (Diluted) (2017 - 2026)

Theravance Biopharma (TBPH) EPS (Diluted) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Theravance Biopharma 864.56 Mn 469.90 Mn - -0.10

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.10
Dec 31, 2025 0.56
Sep 30, 2025 0.07
Jun 30, 2025 1.08
Mar 31, 2025 -0.27
Dec 31, 2024 -0.32
Sep 30, 2024 -0.26
Jun 30, 2024 -0.34
Mar 31, 2024 -0.24
Dec 31, 2023 -0.10
Sep 30, 2023 -0.17
Jun 30, 2023 -0.28
Mar 31, 2023 -0.34
Dec 31, 2022 0.05
Sep 30, 2022 12.28
Jun 30, 2022 0.24
Mar 31, 2022 0.21
Dec 31, 2021 0.37
Sep 30, 2021 0.28
Jun 30, 2021 0.19